American Vanguard (NYSE:AVD) had its price target hoisted by analysts at Loop Capital from $19.00 to $23.00 in a report released on Tuesday, The Fly reports. The brokerage currently has a “buy” rating on the basic materials company’s stock. Loop Capital’s price objective would suggest a potential upside of 14.60% from the company’s current price.
Separately, TheStreet raised American Vanguard from a “c” rating to a “b-” rating in a research report on Wednesday, February 24th.
AVD stock opened at $20.07 on Tuesday. The stock has a 50-day moving average price of $20.44 and a two-hundred day moving average price of $17.55. American Vanguard has a 12-month low of $11.71 and a 12-month high of $22.49. The company has a current ratio of 2.35, a quick ratio of 1.17 and a debt-to-equity ratio of 0.43. The company has a market cap of $620.20 million, a PE ratio of 54.24 and a beta of 1.02.
Large investors have recently added to or reduced their stakes in the stock. Cim Investment Mangement Inc. lifted its stake in shares of American Vanguard by 28.5% in the fourth quarter. Cim Investment Mangement Inc. now owns 31,717 shares of the basic materials company’s stock worth $492,000 after acquiring an additional 7,037 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in American Vanguard by 0.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 179,852 shares of the basic materials company’s stock valued at $2,792,000 after buying an additional 1,292 shares in the last quarter. SG Americas Securities LLC acquired a new stake in American Vanguard during the fourth quarter valued at approximately $252,000. The Manufacturers Life Insurance Company raised its stake in American Vanguard by 7.6% during the fourth quarter. The Manufacturers Life Insurance Company now owns 19,264 shares of the basic materials company’s stock valued at $299,000 after buying an additional 1,368 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in American Vanguard by 0.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,058,632 shares of the basic materials company’s stock valued at $31,950,000 after buying an additional 11,253 shares in the last quarter. Institutional investors and hedge funds own 76.49% of the company’s stock.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.